Skip to main content
    U

    Universal Health Services Inc (UHS)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $191.98
    -5.82 (-2.94%)

    Market Cap: $11.40B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Universal Health Services Inc (UHS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Universal Health Services (UHS) has a market cap of $11.40B and an enterprise value of $17.33B. Its share count is down 6.64% from a year earlier. Its trailing P/E of 8.5x is below its 10-year median of 12.8x.

    Total Valuation

    Enterprise value is 51.98% above the market cap, as debt exceeds cash.

    Market Cap$11.40B
    Enterprise Value$17.33B
    Latest price (Nov 17, 2026)$191.98

    Key Dates

    The next earnings report is expected on Feb 23, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Sep 1, 2026.

    Next Earnings DateFeb 23, 2027 (expected)
    Last Earnings DateOct 27, 2026
    Last Ex-Dividend DateSep 1, 2026
    Last Payment DateSep 15, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 1.44% in the quarter ended Sep 30, 2026 and shrank 6.00% a year over 2 years.

    Shares Outstanding58.80M
    Shares Change (YoY)-6.64%
    Shares Change (QoQ)-1.44%
    Share Count Growth (2Y CAGR)-6.00%

    Valuation Ratios

    Sales and book value multiples are 0.6x and 1.5x. Its year-end P/E ranged from 10.0x to 15.1x from 2016 to 2025.

    P/E Ratio8.5x
    Forward P/E8.4x
    P/S Ratio0.6x
    Forward P/S0.6x
    P/B Ratio1.5x
    P/TBV Ratio3.9x
    P/FCF Ratio10.1x
    P/OCF Ratio5.5x
    PEG Ratio1.2

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 6.2x EBITDA and 15.4x free cash flow.

    EV / Earnings11.7x
    EV / Sales0.9x
    EV / EBITDA6.2x
    EV / EBIT8.2x
    EV / FCF15.4x

    Price Statistics

    The stock is down 14.54% over 52 weeks and trades 5.40% above its 50-day average.

    Beta (1Y)0.15
    52-Week Change-14.54%
    1-Month Change+5.32%
    3-Month Change+11.53%
    6-Month Change+15.63%
    5-Year Change+41.86%
    10-Year Change+45.85%
    Total Return (1Y)-14.18%
    Total Return (3Y CAGR)+12.52%
    Total Return (5Y CAGR)+9.29%
    Return vs SPY (1Y)-27.51%
    Max Drawdown (1Y)-42.15%
    Max Drawdown (3Y)-42.15%
    Sharpe Ratio (1Y)-0.51
    Correlation with SPY (1Y)0.06
    50-Day Average$182.15
    200-Day Average$176.17
    52-Week Range$139.92 to $245.26
    RSI (14 Days)54.7
    Average Volume (20 Days)787.78K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.37x current liabilities, and total debt is 0.80x shareholder equity.

    Current Ratio1.37x
    Quick Ratio1.28x
    Debt / Equity0.80x
    Debt / EBITDA2.19x
    Debt / FCF5.47x
    Interest Coverage12.07x

    Returns and Efficiency

    Return on invested capital is 11.82% over the last 12 months, against a 5-year average of 10.09%.

    Return on Equity (ROE)19.54%
    Return on Assets (ROA)8.64%
    Return on Invested Capital (ROIC)11.82%
    Return on Capital Employed (ROCE)14.62%
    ROE (5Y Average)15.45%
    ROA (5Y Average)7.07%
    ROIC (5Y Average)10.09%
    Asset Turnover1.13x
    Inventory Turnover36.14x
    Receivables Turnover6.54x
    Cash Conversion Cycle-41 days

    Taxes

    Income tax took 23.62% of pretax income over the last 12 months.

    Income Tax (TTM)$459.16M
    Effective Tax Rate23.62%

    Scores

    UHS has an Altman Z-Score of 2.26, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.

    Altman Z-Score2.26
    Altman Z ZoneGrey
    Piotroski F-Score8 of 9
    Piotroski StrengthStrong

    Income Statement

    Revenue of $18.35B over the last 12 months is up 8.00% from the 12 months before.

    Revenue$18.35B
    Revenue Growth (YoY)+8.00%
    Gross Profit$9.87B
    Operating Income$1.99B
    Pretax Income$1.94B
    Net Income$1.48B
    EBITDA$2.78B
    EBIT$2.12B
    Reported EPS (TTM)$22.70

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 44.21% of the $17.19B in total assets.

    Cash and Equivalents$168.75M
    Total Debt$6.10B
    Net Debt$5.93B
    Net Debt Per Share$100.82
    Working Capital$992.81M
    Shareholder Equity$7.60B
    Book Value Per Share$129.21
    Tangible Book Value$2.86B
    Tangible Book Per Share$48.64
    Total Assets$17.19B
    Total Liabilities$9.44B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $940.95M of capital spending, operating cash flow left $1.12B of free cash flow.

    Operating Cash Flow$2.06B
    Capital Expenditures$940.95M
    Free Cash Flow$1.12B
    FCF Per Share$21.58
    Depreciation and Amortization$660.94M
    Dividends Paid$54.59M
    Share Repurchases$1.08B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 10.85%, against a 5-year average of 9.72%.

    Gross Margin53.76%
    Operating Margin10.85%
    Pretax Margin10.59%
    Net Margin8.09%
    EBITDA Margin15.15%
    EBIT Margin11.55%
    FCF Margin6.08%
    Gross Margin (5Y Average)51.39%
    Operating Margin (5Y Average)9.72%
    Net Margin (5Y Average)6.76%

    Growth

    Revenue grew 9.03% a year over 3 years, and EPS 29.98% a year.

    Revenue Growth (3Y CAGR)+9.03%
    Revenue Growth (5Y CAGR)+8.48%
    EPS Growth (3Y CAGR)+29.98%
    EPS Growth (5Y CAGR)+14.35%
    FCF Growth (3Y CAGR)+47.99%
    FCF Growth (5Y CAGR)-12.21%
    Operating Income Growth (3Y CAGR)+25.72%
    Book Value Per Share Growth (2Y CAGR)+12.17%
    Tangible Book Per Share Growth (2Y CAGR)+25.55%

    Revenue and profit by year

    Dividends and Yields

    UHS pays out 2.29% of earnings as dividends.

    Dividend Per Share (Annual)$0.80
    Dividend Yield0.42%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)0.00%
    Dividend Growth (5Y CAGR)+31.95%
    Payout Ratio2.29%
    FCF Payout Ratio4.90%
    Earnings Yield11.76%
    FCF Yield9.88%
    Buyback Yield9.43%
    Shareholder Yield9.91%

    Full dividend history

    Stock Splits

    The last split was a 2-for-1 forward split on Dec 16, 2009.

    Last Split DateDec 16, 2009
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 12 similar companies, UHS has the lowest P/E and the 12th highest P/S.

    P/E Ratio8.5x vs 21.7x median
    P/S Ratio0.6x vs 1.6x median
    ROIC11.82% vs 14.52% median
    Revenue Growth (Trailing 4 Quarters, YoY)+8.00% vs +6.30% median
    Dividend Yield0.42% vs 0.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 5.95% and EPS growth at 2.83% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+5.95%
    EPS Growth Forecast (2Y CAGR)+2.83%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About UHS

    What is UHS's market cap?

    Universal Health Services has a market cap of $11.40B. Its enterprise value, which adds debt and subtracts cash, is $17.33B.

    What is UHS's P/E ratio?

    Universal Health Services has a trailing P/E ratio of 8.5x and a forward P/E of 8.4x.

    How many shares of UHS are outstanding?

    Universal Health Services has 58.80M shares outstanding. The count is down 6.64% from a year earlier.

    Does UHS pay a dividend?

    Yes. Universal Health Services pays $0.80 a share a year, a dividend yield of 0.42%.

    How much debt does UHS have?

    Universal Health Services has $6.10B of total debt and $168.75M of cash and equivalents, a net debt position of $5.93B.